Pharmacists Are Critical In Opioid Use Disorder Care - Pharmacy Practice News

The SUPPORT for Patients and Communities Reauthorization Act, signed into law in 2025, grants pharmacists greater autonomy to prescribe buprenorphine for opioid use disorder after completing specialized training. In a new article in Pharmacy Practice News, two clinical pharmacists describe how they are already providing OUD care across VA, hospital, and community settings — and why state scope-of-practice laws must evolve to match what federal law now permits.